TS23 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-31 in 25d
ESTIMATED |
READOUT
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) T
Phase 2 · Pulmonary Embolism |
Translational Sciences, Inc. | TS23 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|